Financial Ratios

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE171.757.75 (+4.73 %)
PREV CLOSE ( ) 164.00
OPEN PRICE ( ) 164.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 65456
TODAY'S LOW / HIGH ( )164.00 172.20
52 WK LOW / HIGH ( )76.08 230
NSE171.358.15 (+4.99 %)
PREV CLOSE( ) 163.20
OPEN PRICE ( ) 163.05
BID PRICE (QTY) 171.35 (5000)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 138150
TODAY'S LOW / HIGH( ) 163.05 171.35
52 WK LOW / HIGH ( )76.1 229.8
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)9.406.390.254.763.10
   CEPS(Rs)13.6810.213.898.366.35
   DPS(Rs)3.002.500.000.001.60
   Book NAV/Share(Rs)41.3935.5029.7529.2126.62
   Tax Rate(%)26.4825.8645.699.4836.32
Margin Ratios
   Core EBITDA Margin(%)13.7212.876.5710.4010.25
   EBIT Margin(%)11.069.291.246.516.53
   Pre Tax Margin(%)10.678.900.705.805.66
   PAT Margin (%)7.846.600.385.253.60
   Cash Profit Margin (%)11.4210.535.819.227.38
Performance Ratios
   ROA(%)16.9413.120.5310.016.65
   ROE(%)24.4419.600.8617.0511.93
   ROCE(%)34.4627.582.8020.1518.29
   Asset Turnover(x)2.161.991.391.911.84
   Sales/Fixed Asset(x)2.271.921.361.972.01
   Working Capital/Sales(x)11.7613.8924.03444.9768.78
Efficiency Ratios
   Fixed Capital/Sales(x)0.440.520.740.510.50
   Receivable days18.5422.7543.6034.1337.20
   Inventory Days3.063.856.194.484.04
   Payable days
Valuation Parameters
   PER(x)8.279.14211.457.1312.37
   PCE(x)5.685.7313.824.066.04
   Price/Book(x)1.881.651.811.161.44
   Yield(%)3.864.280.000.004.17
   EV/Net Sales(x)0.530.530.760.350.44
   EV/Core EBITDA(x)3.633.9811.363.344.31
   EV/EBIT(x)4.815.6760.975.386.81
   EV/CE(x)1.051.011.080.650.83
   M Cap / Sales0.650.600.800.370.45
Growth Ratio
   Net Sales Growth(%)23.7044.80-26.175.404.72
   Core EBITDA Growth(%)36.88186.74-52.977.1810.41
   EBIT Growth(%)47.26981.00-85.905.0820.02
   PAT Growth(%)46.962415.88-94.6653.5434.64
   EPS Growth(%)46.962415.62-94.6653.5434.64
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.010.09
   Current Ratio(x)1.721.681.221.011.09
   Quick Ratio(x)1.661.581.140.931.03
   Interest Cover(x)28.3824.192.289.147.49
   Total Debt/Mcap(x)0.000.000.000.010.06

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.